• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Health Sciences Campus
    • Brody School of Medicine
    • Physiology
    • View Item
    •   ScholarShip Home
    • Health Sciences Campus
    • Brody School of Medicine
    • Physiology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice

    Thumbnail
    View/ Open
    12933_2014_Article_114.PMC4147179.pdf (2.161Mb)

    Show full item record
    Author
    DuSablon, Augustin; Kent, Susan D.; Coburn, Anita; Virag, Jitka A. I.
    Abstract
    Background We have previously shown that EphrinA1/EphA expression profile changes in response to myocardial infarction (MI), exogenous EphrinA1-Fc administration following MI positively influences wound healing, and that deletion of the EphA2 Receptor (EphA2-R) exacerbates injury and remodeling. To determine whether or not ephrinA1-Fc would be of therapeutic value in the hyperglycemic infarcted heart, it is critical to evaluate how ephrinA1/EphA signaling changes in the hyperglycemic myocardium in response to MI. Methods Streptozotocin (STZ)-induced hyperglycemia in wild type (WT) and EphA2-receptor mutant (EphA2-R-M) mice was initiated by an intraperitoneal injection of STZ (150 mg/kg) 10 days before surgery. MI was induced by permanent ligation of the left anterior descending coronary artery and analyses were performed at 4 days post-MI. ANOVAs with Student-Newman Keuls multiple comparison post-hoc analysis illustrated which groups were significantly different, with significance of at least p < 0.05. Results Both WT and EphA2-R-M mice responded adversely to STZ, but only hyperglycemic EphA2-R-M mice had lower ejection fraction (EF) and fractional shortening (FS). At 4 days post-MI, we observed greater post-MI mortality in EphA2-R-M mice compared with WT and this was greater still in the EphA2-R-M hyperglycemic mice. Although infarct size was greater in hyperglycemic WT mice vs normoglycemic mice, there was no difference between hyperglycemic EphA2-R-M mice and normoglycemic EphA2-R-M mice. The hypertrophic response that normally occurs in viable myocardium remote to the infarct was noticeably absent in epicardial cardiomyocytes and cardiac dysfunction worsened in hyperglycemic EphA2-R-M hearts post-MI. The characteristic interstitial fibrotic response in the compensating myocardium remote to the infarct also did not occur in hyperglycemic EphA2-R-M mouse hearts to the same extent as that observed in the hyperglycemic WT mouse hearts. Differences in neutrophil and pan-leukocyte infiltration and serum cytokines implicate EphA2-R in modulation of injury and the differences in ephrinA1 and EphA6-R expression in governing this are discussed. Conclusions We conclude that EphA2-mutant mice are more prone to hyperglycemia-induced increased injury, decreased survival, and worsened LV remodeling due to impaired wound healing.
    URI
    http://hdl.handle.net/10342/5799
    Subject
     Diabetes; Ischemia; Myocardial infarction; Hyperglycemia; EphrinA1/EphA 
    Date
    2014-08
    Citation:
    APA:
    DuSablon, Augustin, & Kent, Susan D., & Coburn, Anita, & Virag, Jitka A. I.. (August 2014). EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice. Cardiovascular Diabetology, 13(), 1- 16. Retrieved from http://hdl.handle.net/10342/5799

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    DuSablon, Augustin, and Kent, Susan D., and Coburn, Anita, and Virag, Jitka A. I.. "EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice". Cardiovascular Diabetology. 13:. (1-16), August 2014. November 29, 2023. http://hdl.handle.net/10342/5799.
    Chicago:
    DuSablon, Augustin and Kent, Susan D. and Coburn, Anita and Virag, Jitka A. I., "EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice," Cardiovascular Diabetology 13, no. (August 2014), http://hdl.handle.net/10342/5799 (accessed November 29, 2023).
    AMA:
    DuSablon, Augustin, Kent, Susan D., Coburn, Anita, Virag, Jitka A. I.. EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice. Cardiovascular Diabetology. August 2014; 13(): 1-16. http://hdl.handle.net/10342/5799. Accessed November 29, 2023.
    Collections
    • Physiology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback